Paragangliomas Approved for Marketing Phase Trials for Iobenguane (DB06704)

Also known as: Paraganglioma / Paraganglion neoplasm / Paraganglion neoplasm NOS / Neoplasm of paraganglion (disorder) / [M]Paraganglioma NOS (morphologic abnormality) / Gangliocytic paraganglioma (disorder) / Gangliocytic paraganglioma (morphologic abnormality) / Paraganglioma (morphologic abnormality) / Paraganglioma (disorder)

IndicationStatusPhase
DBCOND0051744 (Paragangliomas)Approved for MarketingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01377532Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
NCT02961491Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma